<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hueso M</submitter><funding>Shire Pharmaceutical Spain</funding><funding>Instituto de Salud Carlos III</funding><funding>European Union (ERDF/ESF, “Investing in your future”)</funding><funding>Societat Catalana de Transplantament</funding><pagination>1105-1112</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5128022</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9</volume><pubmed_abstract>Data presented in this Data in Brief article correspond to the article "in vivo" silencing of &lt;i>CD40&lt;/i> reduces progression of experimental atherogenesis through a NFκB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis" (M. Hueso, L. De Ramon, E. Navarro, E. Ripoll, J.M. Cruzado, J.M. Grinyo, J. Torras, 2016) [1]. Here, we describe the validation of the silencing of &lt;i>CD40&lt;/i> expression with a specific siRNA in ApoE&lt;sup>-/-&lt;/sup> mouse aortas, and its systemic effects on splenic lymphocytic subpopulations as well as on the infiltration of aortic intima by F4/80&lt;sup>+&lt;/sup>, galectin-3&lt;sup>+&lt;/sup> macrophages or by NF-κB&lt;sup>+&lt;/sup> cells. We also show the output of a Gene Ontology and TLDA analysis which allowed the detection of potential mediator</pubmed_abstract><journal>Data in brief</journal><pubmed_title>Datasets for the validation of the "in vivo" siRNA-silencing of &lt;i>CD40&lt;/i> and for the detection of new markers of atherosclerosis progression in ApoE-deficient mice.</pubmed_title><pmcid>PMC5128022</pmcid><funding_grant_id>PI11/00556</funding_grant_id><funding_grant_id>PI14/00762</funding_grant_id><funding_grant_id>PI13/00969</funding_grant_id><pubmed_authors>Torras J</pubmed_authors><pubmed_authors>Cruzado JM</pubmed_authors><pubmed_authors>Ripoll E</pubmed_authors><pubmed_authors>De Ramon L</pubmed_authors><pubmed_authors>Navarro E</pubmed_authors><pubmed_authors>Hueso M</pubmed_authors><pubmed_authors>Grinyo JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Datasets for the validation of the "in vivo" siRNA-silencing of &lt;i>CD40&lt;/i> and for the detection of new markers of atherosclerosis progression in ApoE-deficient mice.</name><description>Data presented in this Data in Brief article correspond to the article "in vivo" silencing of &lt;i>CD40&lt;/i> reduces progression of experimental atherogenesis through a NFκB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis" (M. Hueso, L. De Ramon, E. Navarro, E. Ripoll, J.M. Cruzado, J.M. Grinyo, J. Torras, 2016) [1]. Here, we describe the validation of the silencing of &lt;i>CD40&lt;/i> expression with a specific siRNA in ApoE&lt;sup>-/-&lt;/sup> mouse aortas, and its systemic effects on splenic lymphocytic subpopulations as well as on the infiltration of aortic intima by F4/80&lt;sup>+&lt;/sup>, galectin-3&lt;sup>+&lt;/sup> macrophages or by NF-κB&lt;sup>+&lt;/sup> cells. We also show the output of a Gene Ontology and TLDA analysis which allowed the detection of potential mediator</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Dec</publication><modification>2026-04-30T18:14:39.348Z</modification><creation>2019-03-27T02:30:11Z</creation></dates><accession>S-EPMC5128022</accession><cross_references><pubmed>27924297</pubmed><doi>10.1016/j.dib.2016.11.045</doi></cross_references></HashMap>